-+ 0.00%
-+ 0.00%
-+ 0.00%

PHATHOM PHARMACEUTICALS, - TOPLINE RESULTS FROM PHASE 3 STUDY EXPECTED IN Q1 2028

Reuters·09/29/2026 12:00:07

Please log in to view news